LU, Q.; CHANG, C.C.; RICHARDSON, B.C.
Descuento:
-5%Antes:
Despues:
88,87 €Features:
- Discusses the basic biology of skin diseases and skin cancers induced or aggravated by aberrant epigenetic changes.
- Evaluates how to approach autoimmune-related skin diseases from a therapeutic perspective using the wealth of emergent epigenetic clinical trials.
- Offers a coherent and structured table of contents with basic epigenetic biology followed by discussion of the spectrum of rheumatologic through neoplastic skin diseases, finally ending with a discourse on epigenetic therapy.
Authors
- Qianjin Lu, Director, Institute of Dermatology at Central South University, Director of Hunan Key Laboratory of Medical Epigenomics, Changsha, China.
- Christopher C. Chang, Professor of Medicine and Associate Director, Allergy and Immunology Fellowship Program, Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, California, USA.
- Bruce C. Richardson, Professor of Internal Medicine, University of Michigan, Chief Section of Rheumatology, Veterans Affairs Hospital, Ann Arbor, MI, USA.
-5%
-5%
-5%
-5%
-5%
-5%
